Sativa Wellness Group is pleased to announce, further to its news releases dated February 24, 2021 and April 8, 2021, it has closed the second and final tranche of the Company’s non-brokered private placement (the “Offering”) of units (the “Units”). Together with the first tranche closing of the Offering announced by the Company on April 8, 2021, the Company issued an aggregate 58,590,287 Units at a price of $0.07875 per Unit, for aggregate gross proceeds of $4,613,985.10.

Sativa Wellness is pleased to announce the publication of it Financial Statements and Management, Discussion and Analysis report for year ended December 31, 2020. The key highlights of 2020 can be summarised as follows:
2020 Financial Results

The turnover for 2020 was £1,994K (C$3,478K) which was a 38% increase on the previous year (£1,449K) and the gross profit margin at 56% was a 4% increase on the 52% of the previous year. This, in the year of a pandemic, was a great success.

Sativa Wellness is pleased to announce the appointment of Marc Howells as Director and Chief Executive Officer and Anne Tew as Director and Chief Financial Officer of the Company.
The Company wishes to thank both Geremy Thomas for his role as the interim CEO and Joseph Colliver as CFO for their contribution. Geremy Thomas will continue in his role as Executive Chairman.
Marc Howells has been appointed as a Director and CEO effective April 23, 2021 to deliver the Company’s strategy to become one of the best-known wellness brands.

Sativa Wellness Group is pleased to announce that the Company’s subsidiary PhytoVista Laboratories has been granted accreditation to ISO/IEC 17025:2017, General requirements for the competence of testing and calibration laboratories.

Accreditation for the testing of cannabinoids has been granted by United Kingdom Accreditation Service (UKAS), the UK governments appointed National Accreditation Body. The accreditation process determines the technical competence and integrity of organisations such as those offering testing services.

Sativa Wellness Group announces that as part of the recent closure of the first tranche of its non-brokered private placement of units of the Company (each, a “Unit”) previously announced on April 9, 2021 (the “Placement”) Clive Standish, one of the board of directors took part.

Sativa Wellness Group is pleased to announce that it has closed the first tranche of its non-brokered private placement of units of the Company (each, a “Unit”) previously announced on February 24, 2021 (the “Offering”). In this closing, the Company issued an aggregate of 45,888,730 Units at a price of C$0.07875 per Unit for aggregate gross proceeds of C$3,613,737.49.

Sativa Wellness Group is pleased to announce that it is now listed on the UK government website to offer 2 and 8 day quarantine tests (the “Return Tests”) for travellers returning to the UK.

Sativa Wellness Group is pleased to announce that its COVID testing clinic business has achieved in excess of £1,100,000 of bookings (CAD$2,000,000) of bookings. This milestone has been achieved in less than 4 months from the first clinic being opened in Bath, UK.

Sativa Wellness is pleased to announce that its Polish extraction facility has secured accreditation of its Hazard Analysis and Critical Control Point (“HACCP”) system from global quality and certification company LL-C Group, and confirmation that its operations meet the requirements of Good Manufacturing Practice (“GMP”) and Good Hygiene Practice (“GHP”) standards for food manufacturing.

Sativa Wellness Group is pleased to announce that it intends to complete a non-brokered private placement financing (the “Financing”) of units (each, a “Unit”) for gross proceeds of up to CDN$4,000,000 with a price per Unit of CDN$0.07875.

Each Unit will consist of one common share (each, a “Share”) and one half of one common share purchase warrant (each, a “Warrant”), with each Warrant exercisable to acquire one additional Share (each, a “Warrant Share”) for a period of 24 months following the closing date of the Financing (the “Closing Date’). The Warrants shall have an exercise price of CDN$0.105 per Warrant Share. The Warrants are not subject to any acceleration clause.

Sativa Wellness Group is pleased to announce that our Bath and Bristol Goodbody clinics booked up to £27,000 a day in COVID testing revenues in December. Having proved the testing model in Bath and Bristol, we have rolled out a number of in-pharmacy clinics and today we open our tenth testing facility with a further twenty in-pharmacy clinics in process.